Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selcuk Guven

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Minerva Urology and Nephrology|October 23, 2025
Time to personalize antibiotic use in urological surgerySelcuk Guven
Minerva Urology and Nephrology|December 18, 2025
Artificial intelligence as the continuum of surgical evolutionSelcuk Guven
European Urology|April 28, 2009
Editorial comment on: complete continence after botulinum neurotoxin type a injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeksMehmet Kilinc, Selcuk Guven
World Journal of Urology|October 7, 2020
Infections in urology: slow progress reflected in clinical practiceSelcuk Guven, Ali Mert
Minerva Urology and Nephrology|February 16, 2026
Comment on: "Evaluation of inflammatory markers in survival analysis of patients undergoing radical cystectomy using machine learning"Murat Akand, Selcuk Guven
European Urology Focus|April 30, 2026
"Pro/ 'Yes' for PSA Testing Before BPO Surgical Therapy" Ignoring PSA in BPE is Not Progress; It's Clinical BlindnessSelcuk Guven, Thomas Rw Herrmann
World Journal of Urology|January 13, 2025
In all fields anatomical dissection has improved results - en bloc resection of bladder tumors (ERBT) will make no exceptionSelcuk Guven, Thomas R W Herrmann
World Journal of Urology|March 25, 2020
Urinary tuberculosis: still a challengeAli Mert, Vahit Guzelburc, Selcuk Guven
World Journal of Urology|April 28, 2020
Recurrent bladder cystitis: who takes the role?Mustafa Soytas, Cagri Kactan, Selcuk Guven
Current Opinion in Urology|October 12, 2018
Can ablation win against partial nephrectomy and become first line therapy in cT1a renal tumours?Laura Sandbergen, Selcuk Guven, Maria Pilar Laguna
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Minerva Urology and Nephrology|October 23, 2025
Time to personalize antibiotic use in urological surgerySelcuk Guven
Minerva Urology and Nephrology|December 18, 2025
Artificial intelligence as the continuum of surgical evolutionSelcuk Guven
European Urology|April 28, 2009
Editorial comment on: complete continence after botulinum neurotoxin type a injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeksMehmet Kilinc, Selcuk Guven
World Journal of Urology|October 7, 2020
Infections in urology: slow progress reflected in clinical practiceSelcuk Guven, Ali Mert
Minerva Urology and Nephrology|February 16, 2026
Comment on: "Evaluation of inflammatory markers in survival analysis of patients undergoing radical cystectomy using machine learning"Murat Akand, Selcuk Guven
European Urology Focus|April 30, 2026
"Pro/ 'Yes' for PSA Testing Before BPO Surgical Therapy" Ignoring PSA in BPE is Not Progress; It's Clinical BlindnessSelcuk Guven, Thomas Rw Herrmann
World Journal of Urology|January 13, 2025
In all fields anatomical dissection has improved results - en bloc resection of bladder tumors (ERBT) will make no exceptionSelcuk Guven, Thomas R W Herrmann
World Journal of Urology|March 25, 2020
Urinary tuberculosis: still a challengeAli Mert, Vahit Guzelburc, Selcuk Guven
World Journal of Urology|April 28, 2020
Recurrent bladder cystitis: who takes the role?Mustafa Soytas, Cagri Kactan, Selcuk Guven
Current Opinion in Urology|October 12, 2018
Can ablation win against partial nephrectomy and become first line therapy in cT1a renal tumours?Laura Sandbergen, Selcuk Guven, Maria Pilar Laguna
Pageof 9